Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 4705 - 4712 of 12104 results

MintzEdge 101: FDA for Start-Ups

January 14, 2020| Podcast| Viewpoint

Cures Act Developments: FDA Publishes CFR Amendments Exempting Class II Devices with an Interesting Addition

January 13, 2020| Blog| Viewpoint

2019 Trends In DOJ Health Care Enforcement

January 13, 2020| News

New Policy Guidance on Good Moral Character Determinations

January 10, 2020| Blog| Viewpoint

New Injunction Policy Boosts Power Of Essential Patents

January 10, 2020| News

FCC Kicks Off 2020 by Establishing the Rural Digital Opportunity Fund

January 10, 2020| Alert| Viewpoint

Is Your Company Still Running Windows 7? READ THIS!

January 10, 2020| Blog| Viewpoint

California’s Ban on Mandatory Employment Arbitration Stayed for Now

January 10, 2020| Blog| Viewpoint

News & Press Releases

Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree

August 19, 2025

Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.

Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement

August 18, 2025

Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.

Mintz Advises the Underwriters in Ondas Holdings’ $173 Million Public Offering

August 18, 2025

Mintz advised the underwriters in connection with the $173 million public offering by Ondas Holdings Inc. of 53,084,000 shares of its common stock, which includes 6,924,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.

View all News and Press Releases